Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 235

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 235
---
 omitted as permitted by SEC rules and regulations. For further information concerning us and the
securities offered by this prospectus, we refer to the Registration Statement and to the exhibits filed with it. Statements contained
in this prospectus as to the content of any contract or other document referred to are not necessarily complete. In each instance, we
refer you to the copy of the contracts and/or other documents filed as exhibits to the Registration Statement.

The Registration Statement
on Form S-1, of which this prospectus forms a part, including exhibits, is available at the SEC’s website at http://www.sec.gov.
You may also read and copy any document we file with, or furnish to, the SEC at its public reference facilities:

Public Reference Room Office

100 F Street, N.E.

Room 1580

Washington, D.C. 20549

You may also obtain copies
of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington,
D.C. 20549. Callers in the United States can also call (202) 551-8090 for further information on the operations of the public reference
facilities.

| 133 |

<div align='center'>JUPITER NEUROSCIENCES, INC.

INDEX TO FINANCIAL STATEMENTS</div>

| Report of Independent Registered Public Accounting Firm                                                                           
 Balance Sheets, as of December 31, 2024 and 2023 (Audited)                                                                        
 Statements of Operations for the Years Ended December 31, 2024 and 2023 (Audited)                                                 |     | F-1  
 F-2  
 F-3  |
|:----------------------------------------------------------------------------------------------------------------------------------|:----|:-----|
| Statements of Changes in                                                                                                          
 Stockholder’s Deficit for the ™Years Ended December 31, 2024 and 2023 (Audited)                                                   |     | F-4  |
| Statements of Cash Flows for the Years Ended December 31, 2024 and 2023 (Audited)                                                 |     | F-5  |
| Notes to Financial Statements                                                                                                     |     | F-6  |
| Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024                                                         |     | F-25 |
| Statements of Operations for the Three Months and Nine Months Ended September 30, 2025 and 2024